<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04980820</url>
  </required_header>
  <id_info>
    <org_study_id>1144/2021</org_study_id>
    <nct_id>NCT04980820</nct_id>
  </id_info>
  <brief_title>Changes in Capillary Carbon Dioxide Partial Pressure (pCO2) While Wearing FFP2 / FFP3 Masks</brief_title>
  <official_title>Changes in Capillary pCO2 While Wearing FFP2 and FFP3 Masks Masks by Medical Staff - a Prospective Cross-over Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to determine whether there are any changes in the carbon dioxide&#xD;
      partial pressure in medical staff while wearing a filtering face piece (FFP) 2 or FFP3 mask.&#xD;
&#xD;
      Furthermore, changes in the capillary oxygen partial pressure, the subjective respiratory&#xD;
      effort and the breathing rate are measured.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the fight against the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2),&#xD;
      the personal protective equipment (PPE) of medical staff plays a special role. Since the&#xD;
      pathogen can be transmitted via droplets, particle-filtering half masks (filtering face piece&#xD;
      - FFP) are a substantial part of the PPE. The current data indicate that there may be an&#xD;
      increase in the carbon dioxide partial pressure (PcCO2) in the blood when wearing an FFP2 / 3&#xD;
      mask during routine medical activity.&#xD;
&#xD;
      The aim of this prospective cross-over study is to compare the PcCO2 measured by capillary&#xD;
      blood sampling from medical staff while wearing an FFP2 or FFP3 mask. The PcCO2 determined&#xD;
      without a mask serves as a reference value. While no mask is worn, the PcCO2, the subjective&#xD;
      respiratory effort, the breathing rate and the capillary oxygen partial pressure (PcO2) is&#xD;
      measured. The study participants then wear an FFP2 or FFP3 mask for one hour, and the same&#xD;
      parameters are collected. Subsequently, the participant switches to an FFP3 or FFP2 mask, and&#xD;
      the last measurement is conducted after one hour.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 19, 2021</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>arm: starts with no mask - FFP2 mask - FFP3 mask&#xD;
arm: starts with no mask - FFP3 mask - FFP2 mask</intervention_model_description>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of PcCO2</measure>
    <time_frame>1. measurement after 10 minutes without mask, 2. measurement after 1 hour with mask (FFP2/3), 3. measurement after 1 hour with mask (FFP3/2)</time_frame>
    <description>Change of capillary carbon dioxide partial pressure (PcCO2)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of PcO2</measure>
    <time_frame>1. measurement after 10 minutes without mask, 2. measurement after 1 hour with mask (FFP2/3), 3. measurement after 1 hour with mask (FFP3/2)</time_frame>
    <description>Change of capillary oxygen partial pressure (PcO2)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory rate</measure>
    <time_frame>1. measurement after 10 minutes without mask, 2. measurement after 1 hour with mask (FFP2/3), 3. measurement after 1 hour with mask (FFP3/2)</time_frame>
    <description>Number of breaths per minute</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exertion score</measure>
    <time_frame>1. measurement after 10 minutes without mask, 2. measurement after 1 hour with mask (FFP2/3), 3. measurement after 1 hour with mask (FFP3/2)</time_frame>
    <description>Participant subjective score: &quot;How difficult is it for you to breathe at the moment?&quot;; scale from 1-5, 1= easy, 2= rather easy, 3= moderate, 4= rather hard, 5= hard</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Hypercapnia</condition>
  <arm_group>
    <arm_group_label>FFP2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm starts with a FFP2 mask and switches to a FFP3 mask.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FFP3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This arm starts with a FFP3 mask and switches to a FFP2 mask.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No mask</intervention_name>
    <description>The participant is asked to wear no mask for 10 minutes.</description>
    <arm_group_label>FFP2</arm_group_label>
    <arm_group_label>FFP3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Filtering face mask 2 (FFP2)</intervention_name>
    <description>The participant is asked to wear a FFP2 mask for 1 hour during work.</description>
    <arm_group_label>FFP2</arm_group_label>
    <arm_group_label>FFP3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Filtering face mask 3 (FFP3)</intervention_name>
    <description>The participant is asked to wear a FFP3 mask for 1 hour during work.</description>
    <arm_group_label>FFP2</arm_group_label>
    <arm_group_label>FFP3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  medical staff working at the Vienna General Hospital&#xD;
&#xD;
          -  oral and written consent to take part voluntarily in this trial&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  hypersensitivity / allergy against Nonylvanillamid, Nikotinsäure-beta-butoxyethylester&#xD;
             or other component of &quot;Finalgon Salbe&quot;&#xD;
&#xD;
          -  not Coronavirus disease-19 vaccinated&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  breastfeeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Georg Röder, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Vienna, Dept. of Anaesthesiology, Critical Care and Pain Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Georg Röder, M.D.</last_name>
    <phone>+43 (0)1 40400 - 24680</phone>
    <email>georg.roeder@meduniwien.ac.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>David Baron, M.D., PD.</last_name>
    <phone>+43 (0)1 40400 - 24680</phone>
    <email>david.baron@meduniwien.ac.at</email>
  </overall_contact_backup>
  <link>
    <url>https://www.who.int/publications/i/item/rational-use-of-personal-protective-equipment-for-coronavirus-disease-(covid-19)-and-considerations-during-severe-shortages</url>
    <description>Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages</description>
  </link>
  <reference>
    <citation>Paules CI, Marston HD, Fauci AS. Coronavirus Infections-More Than Just the Common Cold. JAMA. 2020 Feb 25;323(8):707-708. doi: 10.1001/jama.2020.0757.</citation>
    <PMID>31971553</PMID>
  </reference>
  <reference>
    <citation>Fletcher SJ, Clark M, Stanley PJ. Carbon dioxide re-breathing with close fitting face respirator masks. Anaesthesia. 2006 Sep;61(9):910.</citation>
    <PMID>16922771</PMID>
  </reference>
  <reference>
    <citation>Özdemir L, Azizoğlu M, Yapıcı D. Respirators used by healthcare workers due to the COVID-19 outbreak increase end-tidal carbon dioxide and fractional inspired carbon dioxide pressure. J Clin Anesth. 2020 Nov;66:109901. doi: 10.1016/j.jclinane.2020.109901. Epub 2020 May 22.</citation>
    <PMID>32473501</PMID>
  </reference>
  <reference>
    <citation>Kim JH, Benson SM, Roberge RJ. Pulmonary and heart rate responses to wearing N95 filtering facepiece respirators. Am J Infect Control. 2013 Jan;41(1):24-7. doi: 10.1016/j.ajic.2012.02.037. Epub 2012 Sep 1.</citation>
    <PMID>22944510</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 14, 2021</study_first_submitted>
  <study_first_submitted_qc>July 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 28, 2021</study_first_posted>
  <last_update_submitted>July 19, 2021</last_update_submitted>
  <last_update_submitted_qc>July 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>David M Baron, MD</investigator_full_name>
    <investigator_title>Assoc. Prof. PD Dr. David Baron, EDIC</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypercapnia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

